Magnetic resonance imaging for the diagnosis of Parkinson's disease

B Heim, F Krismer, R De Marzi, K Seppi - Journal of neural transmission, 2017 - Springer
The differential diagnosis of parkinsonian syndromes is considered one of the most
challenging in neurology and error rates in the clinical diagnosis can be high even at …

A delicate balance: Iron metabolism and diseases of the brain

D Hare, S Ayton, A Bush, P Lei - Frontiers in aging neuroscience, 2013 - frontiersin.org
Iron is the most abundant transition metal within the brain, and is vital for a number of
cellular processes including neurotransmitter synthesis, myelination of neurons, and …

The 'swallow tail'appearance of the healthy nigrosome–a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T

ST Schwarz, M Afzal, PS Morgan, N Bajaj… - PloS one, 2014 - journals.plos.org
There is no well-established in vivo marker of nigral degeneration in Parkinson's disease
(PD). An ideal imaging marker would directly mirror the loss of substantia nigra …

Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2

JHO Barbosa, AC Santos, V Tumas, M Liu… - Magnetic resonance …, 2015 - Elsevier
Purpose To evaluate the sensitivity and specificity of quantitative magnetic resonance (MR)
iron mapping including R2, R2* and magnetic susceptibility to differentiate patients with …

Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature

P Péran, A Cherubini, F Assogna, F Piras… - Brain, 2010 - academic.oup.com
One objective of modern neuroimaging is to identify markers that can aid in diagnosis,
disease progression monitoring and long-term drug impact analysis. In this study, Parkinson …

Practical medical applications of quantitative MR relaxometry

HL Margaret Cheng, N Stikov… - Journal of Magnetic …, 2012 - Wiley Online Library
Conventional MR images are qualitative, and their signal intensity is dependent on several
complementary contrast mechanisms that are manipulated by the MR hardware and …

Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's …

DB Kell - Archives of toxicology, 2010 - Springer
Exposure to a variety of toxins and/or infectious agents leads to disease, degeneration and
death, often characterised by circumstances in which cells or tissues do not merely die and …

Neuromelanin imaging and dopaminergic loss in Parkinson's disease

IU Isaias, P Trujillo, P Summers, G Marotta… - Frontiers in aging …, 2016 - frontiersin.org
Parkinson's disease (PD) is a progressive neurodegenerative disorder in which the major
pathologic substrate is a loss of dopaminergic neurons from the substantia nigra. Our main …

Quantitative susceptibility mapping of the midbrain in Parkinson's disease

G Du, T Liu, MM Lewis, L Kong, Y Wang… - Movement …, 2016 - Wiley Online Library
Background Parkinson's disease (PD) is marked pathologically by dopamine neuron loss
and iron overload in the substantia nigra pars compacta. Midbrain iron content is reported to …

T2 mapping from highly undersampled data by reconstruction of principal component coefficient maps using compressed sensing

C Huang, CG Graff, EW Clarkson… - Magnetic resonance …, 2012 - Wiley Online Library
Recently, there has been an increased interest in quantitative MR parameters to improve
diagnosis and treatment. Parameter mapping requires multiple images acquired with …